









Markets
/
Stocks
/
nasdaq-immx
/

Immix Biopharma Inc

IMMX

2.540USD

-0.110-4.15%

Close 08/04, 16:00（ET）Quotes delayed by 15 min

70.74MMarket Cap

LossP/E TTM



Immix Biopharma Inc

2.540

-0.110-4.15%

Overview Company Financials

Overview

Company

Financials

Statements

Income Statement

Balance Sheet

Cash Flow Statement

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2020Q4

FY2020Q3

Operating cash flows (indirect method)

Cash flow from continuing operating activities

55.97%-1.69M

44.87%-1.48M

-30.76%-4.04M

-49.52%-5.26M

-82.93%-3.83M

31.42%-2.68M

-111.06%-3.09M

-542.58%-3.52M

-39.95%-2.09M

-250.41%-3.90M

-2781.24%-1.46M

---547.07K

---1.49M

-800.98%-1.11M

29.23%-50.76K

--158.93K

---71.72K

Net income from continuing operations

14.79%-4.54M

6.66%-4.81M

-64.58%-7.15M

-22.45%-4.41M

-113.41%-5.33M

-35.67%-5.16M

-182.98%-4.34M

-130.24%-3.60M

-87.53%-2.50M

83.30%-3.80M

-280.66%-1.54M

---1.56M

---1.33M

-2872.31%-22.76M

-246.69%-403.26K

---765.58K

---116.32K

Operating gains losses

148.13%59.18K

1243.86%41.34K

1775.89%25.91K

4701.38%24.30K

4622.77%23.85K

443.46%3.08K

143.99%1.38K

32.11%506.00

-18.55%505.00

-8.71%566.00

--383.00

--620.00

6.71%620.00

6.90%620.00

--581.00

--580.00

Other non-cash items

----

--20.46K

--20.42K

--20.84K

----

-100.00%0.00

148.50%50.00K

--50.00K

--0.00

3748.28%22.13M

--20.12K

--575.00K

--0.00

Change in working capital

259.31%1.93M

81.80%2.59M

353.88%2.35M

-313.98%-1.51M

610.34%537.10K

525.41%1.42M

467.25%518.55K

-140.61%-365.30K

133.10%75.61K

45.05%-334.75K

-152.31%-141.20K

--899.62K

---228.47K

-274.58%-609.16K

513.17%269.90K

--348.93K

--44.02K

-Change in receivables

319.80%2.00M

51.76%-224.78K

118.03%68.54K

285.79%96.25K

-1162.73%-911.54K

-664.45%-465.93K

-1199.60%-380.24K

122.64%24.95K

-100.75%-72.19K

-135.73%-60.95K

-37.41%-29.26K

---110.22K

---35.96K

-18.34%170.60K

37.79%-21.29K

--208.92K

---34.23K

-Change in prepaid expenses

33.62%-316.62K

-47.20%546.84K

-35.90%286.41K

114.95%198.51K

-1009.12%-476.99K

215.26%1.04M

104.40%446.83K

-487.45%-1.33M

87.84%-43.01K

-79.77%-898.59K

2403.27%218.60K

--342.68K

---353.74K

-28480.16%-499.87K

-179.09%-9.49K

---1.75K

--12.00K

-Change in payables and accrued expense

-86.56%258.72K

167.04%2.28M

342.69%2.00M

-292.53%-1.80M

908.74%1.92M

36.72%854.22K

236.73%451.96K

38.57%937.49K

18.57%190.81K

303.58%624.79K

-223.58%-330.54K

--676.56K

--160.93K

-360.63%-306.89K

521.90%267.47K

--117.75K

--43.01K

-Change in other current assets

----

--0.00

---20.42K

----

Cash from non-recurring investing activities

Cash from operating activities

55.97%-1.69M

44.87%-1.48M

-30.76%-4.04M

-49.52%-5.26M

-82.93%-3.83M

31.42%-2.68M

-111.06%-3.09M

-542.58%-3.52M

-39.95%-2.09M

-250.41%-3.90M

-2781.24%-1.46M

---547.07K

---1.49M

-800.98%-1.11M

29.23%-50.76K

--158.93K

---71.72K

Investing cash flow

Net cash from continuing investing activities

-77.57%67.71K

3748.76%507.15K

597.84%271.54K

--97.07K

--301.91K

--13.18K

--38.91K

----

--0.00

Capital expenditures

-77.57%67.71K

3748.76%507.15K

597.84%271.54K

--97.07K

--301.91K

--13.18K

--38.91K

----

--0.00

Net cash flow from disposal of fixed assets

-77.57%67.71K

3748.76%507.15K

597.84%271.54K

--97.07K

--301.91K

--13.18K

--38.91K

----

--0.00

Cash from non-current investing activities

Net cash flow from investing activities

77.57%-67.71K

-3748.76%-507.15K

-597.84%-271.54K

---97.07K

---301.91K

---13.18K

---38.91K

----

--0.00

Financing cash flow

Cash flow from continuous financing activities

----

-100.00%0.00

13311.62%15.95M

38.28%586.69K

--10.07M

4527.64%4.69M

-95.92%118.92K

-97.73%424.28K

100.00%0.00

---105.96K

--2.91M

--18.72M

---18.35K

--0.00

Net cash flow from debt Issuance/repayment

----

--0.00

100.00%0.00

----

--0.00

---50.00K

--0.00

Net cash flow from common stock issuance/repurchase

----

-100.00%0.00

5617.16%15.95M

1427.44%584.07K

--10.13M

8511.77%4.71M

-90.43%278.92K

-100.24%-44.00K

--0.00

---55.96K

--2.91M

--18.65M

----

Proceeds from stock option exercised by employees

----

-100.00%0.00

--0.00

--2.49K

--2.62K

----

Net cash flow from other financing activities

----

100.00%0.00

-100.00%1.00

---58.80K

---15.82K

---160.00K

559.34%468.28K

100.00%0.00

--0.00

--71.02K

---18.35K

--0.00

Net cash from non-recurrent financing activities

Net cash from financing activities

----

-100.00%0.00

13311.62%15.95M

38.28%586.69K

--10.07M

4527.64%4.69M

-95.92%118.92K

-97.73%424.28K

100.00%0.00

---105.96K

--2.91M

--18.72M

---18.35K

--0.00

Net cash flow

Beginning cash balance

0.98%17.68M

0.55%19.69M

89.47%23.98M

155.77%29.32M

30.31%17.51M

15.76%19.58M

-31.24%12.65M

-39.86%11.46M

-23.85%13.44M

44423.02%16.92M

16538.50%18.40M

--19.06M

--17.64M

-79.79%37.99K

-56.46%110.60K

--188.03K

--254.01K

Current period cash flow changes

-114.91%-1.76M

3.10%-2.01M

-161.84%-4.28M

-548.92%-5.34M

698.36%11.81M

40.44%-2.07M

566.33%6.93M

280.83%1.19M

-239.36%-1.97M

-119.76%-3.48M

-1946.43%-1.49M

---658.33K

--1.42M

8570.80%17.61M

-10.04%-72.61K

--203.06K

---65.98K

Effect of exchange rate changes

22.82%-8.00K

-180.31%-25.13K

295.07%22.96K

-36.97%8.91K

-1744.48%-10.37K

20028.66%31.29K

49.57%-11.77K

366.53%14.14K

79.35%-562.00

-125.28%-157.00

-567.27%-23.34K

---5.30K

---2.72K

-98.59%621.00

-160.92%-3.50K

--44.12K

--5.74K

Ending cash balance

-45.70%15.92M

0.98%17.68M

0.55%19.69M

89.47%23.98M

155.77%29.32M

30.31%17.51M

15.76%19.58M

-31.24%12.65M

-39.86%11.46M

-23.85%13.44M

44423.02%16.92M

--18.40M

--19.06M

4411.66%17.64M

-79.79%37.99K

--391.09K

--188.03K

Free cash flow

57.55%-1.75M

26.29%-1.98M

-37.82%-4.31M

---5.35M

---4.13M

31.08%-2.69M

-113.72%-3.13M

----

-250.41%-3.90M

-2781.24%-1.46M

---547.07K

---1.49M

-800.98%-1.11M

29.23%-50.76K

--158.93K

---71.72K

Currency unit

USD

Audit opinions

KeyAI

